The company is betting on medical-to-recreational transitions in already-staked markets.
The company is betting on medical-to-recreational transitions in already-staked markets.
The move is part of an expansion quest.
Awakn partnered with Orphan Insight Ltd., which provides consulting on bringing novel drug therapies to market.
The passage is seen as an attempt to address imbalances within the market.
The company has been on a cost-cutting quest after losing billions.
Flower represented more than half of all cannabis sales for the state.
The Michigander has been suing state and city governments over cannabis licensing residency requirements.
The company's results had been delayed after accountants previously discovered unreliable financial statements.
The legislation also mandates a disparity study.
Curaleaf USA will have a director appointed by an investor.
Unpack the industry with the daily cannabis newsletter for business leaders.